Colorado Voters Navigate Judicial Retention Decisions Amid Complex Ballot Questions

DENVER, Colo. — As Colorado gears up for its Nov. 5 elections, voters are confronted with an essential, albeit daunting, choice: deciding whether state and county judges should stay on the bench. In this unique judicial approach, judges are not elected but instead appointed and later placed on the ballot for retention, making Colorado’s system a blend of appointment and public accountability. Colorado operates under a distinct judicial system where judges across various courts are appointed rather than elected. Later, these judges face retention elections, which allow citizens to vote on whether they should continue … Read more

Striking the Right Balance: How Corporate Legal Leaders Navigate Innovation and Risk

New York — As businesses increasingly rely on technology to push the boundaries of what’s possible, corporate legal departments are finding themselves at a critical crossroads. Striking the right balance between fostering innovation and mitigating risk has become a central challenge for legal professionals in the corporate domain. This balancing act is not only transformative but also fraught with potential pitfalls if not managed carefully. Today’s corporate attorneys are not just legal advisors but strategic partners in innovation. As companies venture into new areas like artificial intelligence, blockchain, and data analytics, the role of legal … Read more

Purdue Pharma Faces Intense Scrutiny as Bankruptcy Trustees Navigate Complex Mass Tort Litigation

Stamford, Conn.— Purdue Pharma, the company widely criticized for its role in the opioid crisis, has reached a critical juncture in its Chapter 11 bankruptcy proceedings that could significantly impact the landscape of mass tort litigation in the United States. Facing thousands of lawsuits, the pharmaceutical giant filed for bankruptcy in 2019 as part of an effort to settle claims alleging it fueled a national addiction epidemic with its aggressive marketing of the painkiller OxyContin. The latest proposal in Purdue Pharma’s bankruptcy case, which aims to resolve multitudes of opioid lawsuits, stipulates that the Sackler … Read more

Weight-Loss Drug Makers Navigate U.S. Litigation Landscape: Lessons from the Past and Strategies for Future Defense

Washington, D.C. – Amid booming sales, manufacturers of GLP-1 weight-loss drugs face a new challenge: the potential for mass tort litigation similar to what has historically rocked other sectors of the American pharmaceutical industry. Industry experts suggest that drawing lessons from past litigations could be key to these manufacturers not just surviving but thriving in an increasingly litigious environment. GLP-1, or glucagon-like peptide-1 receptor agonists, have gained attention not only for their effectiveness in obesity management but also for potential side effects which could become the focal point of legal battles. Given the aggressive nature … Read more